Bioheart (02185.HK) anuncia el resultado clínico de Iberis-HTN en el CIT 2023 ...Middle East

PR Newswire - News
SHANGHÁI, 2 de julio de 2023 /PRNewswire/ -- Bioheart (02185.HK), junto con su subsidiaria de cartera Angiocare, anuncia el resultado clínico de Iberis-HTN en China Interventional Therapeutics 2023. Iberis-HTN es un ensayo controlado prospectivo, multicéntrico, ciego y aleatorizado para...

Hence then, the article about bioheart 02185 hk anuncia el resultado clinico de iberis htn en el cit 2023 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bioheart (02185.HK) anuncia el resultado clínico de Iberis-HTN en el CIT 2023 )

Apple Storegoogle play

Last updated :

Also on site :



Latest News